DNA Brands, Inc. (OTCPINK: DNAX) saw its share volume explode on June 9th with 277,516,100 shares exchanging hands, 34 times higher than its three month daily average volume of 7,972,520 shares.
This surge in volume comes after DNA Brands announced today that Trenton Coca-Cola Bottling Co. has agreed to distribute the DNA line of products.
President and CEO of DNA, Eric Fowler, said, "We are elated to have such a premier distributor as Trenton Coca-Cola, now carrying our line of products. Having DNA now available in the Northern Missouri market helps us immensely as we continue our Midwest expansion. We are fortunate to have this opportunity to work with Trenton Coca-Cola and plan on taking our success into additional markets." Fowler continued, "Being able to announce this Missouri agreement on the heels of last week's Texas expansion news shows that our efforts over the past several months to increase distribution of our products is now beginning to bear fruit. We also feel that this is just the beginning and look forward to adding significantly to this initial success."
Chuck Jones, President of Trenton Coca-Cola, said, "We are excited about the opportunity to launch these exciting products and look forward to working with the DNA management team to develop our market."
DNAX closed the day at $.015, 525% higher than its previous close of $.0024.
PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:
Active Health Foods Signs Distribution Contract with Queathem and Associates
Active Health Foods, Inc. (OTCPINK: AHFD) saw its share volume skyrocket on June 9th with 178,583,651 shares exchanging hands, 56 times higher than its three month daily average volume of 3,175,763 shares.
Just last week, Active Health Foods announced that Queathem & Associates, Inc. is now under contract with Active Health Foods as its broker and sale agent for both regional and national distribution.
Some of the relationships that Queathem & Associates, Inc. will take advantage of are Drug Chains like Rite Aid and Walgreens, Convenience Store Chains like Circle K and 7-Eleven, and Wholesale Giants Costco and Sam's Club to name a few.
"Our products are both 'one of a kind' in a huge pool of available products in their separate categories, we are excited to offer the consumer access to our top-quality products along with our commitment to offer only good for you, better for you, products and the opportunity for a 'healthier lifestyle'," explains Active Health Foods, Inc. President Greg Manos. "We spare no expense in making products that live up to our commitment and we believe their individual successes are eminent," he adds.
"Currently Active Health Foods, Inc. products are available through its website and network marketing representatives with limited exposure and less than satisfying distribution. Signing the agreement with Queathem & Associates, Inc. a California-based Food and Beverage Sales, Marketing, and Consulting firm opens the doors for much needed and timely expanded distribution, 'product placement,' and consumer availability and as we move forward we are excited about the associations and relationships Queathem & Associates, Inc. has with their network of Brokers and Distributors for expansion across the United States," Greg concludes.
AHFD closed the day at $.003, 87.5% higher than its previous close of $.0016.
Cocrystal Pharma Sees Share Volume Rise
Cocrystal Pharma, Inc. (OTCQB: COCP) saw its share volume soar on June 9th with 1,558,631 shares exchanging hands, three times higher than its three month daily average volume of 477,157 shares.
With no recent news being released about Cocrystal Pharma, one can only speculate why this uptick in volume occurred, but here is what is known about the company:
Cocrystal Pharma, Inc., a preclinical-stage biopharmaceutical company, intends to develop medicines for use in treating human viral diseases. The company focuses on developing inhibitors of viral replication enzymes that are essential to viral replication. It is developing antiviral therapeutics for human diseases, including Hepatitis C virus, Influenza virus, Rhinovirus, Dengue Virus, and Norovirus. The company also develops targeted in-house chemical libraries consisting of antiviral compounds of various types, including non-nucleoside inhibitors, metal-binding inhibitors, and fragments. In addition, it is developing compounds that inhibit HCV helicase, an enzyme that is essential for hepatitis C viral replication.
COCP closed the day at $.33.
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.pennypickalerts.com
Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.